156 related articles for article (PubMed ID: 12843571)
1. [Gingipains as the determinants of periodontopathogenicity].
Kadowaki T; Takii R; Baba A; Yamamoto K
Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):37-44. PubMed ID: 12843571
[TBL] [Abstract][Full Text] [Related]
2. Porphyromonas gingivalis gingipains: the molecular teeth of a microbial vampire.
O-Brien-Simpson NM; Veith PD; Dashper SG; Reynolds EC
Curr Protein Pept Sci; 2003 Dec; 4(6):409-26. PubMed ID: 14683427
[TBL] [Abstract][Full Text] [Related]
3. Suppression of virulence of Porphyromonas gingivalis by potent inhibitors specific for gingipains.
Kadowaki T; Yamamoto K
Curr Protein Pept Sci; 2003 Dec; 4(6):451-8. PubMed ID: 14683430
[TBL] [Abstract][Full Text] [Related]
4. The role of gingipains in the pathogenesis of periodontal disease.
Imamura T
J Periodontol; 2003 Jan; 74(1):111-8. PubMed ID: 12593605
[TBL] [Abstract][Full Text] [Related]
5. Suppression of pathogenicity of Porphyromonas gingivalis by newly developed gingipain inhibitors.
Kadowaki T; Baba A; Abe N; Takii R; Hashimoto M; Tsukuba T; Okazaki S; Suda Y; Asao T; Yamamoto K
Mol Pharmacol; 2004 Dec; 66(6):1599-606. PubMed ID: 15361547
[TBL] [Abstract][Full Text] [Related]
6. Generation of lys-gingipain protease activity in Porphyromonas gingivalis W50 is independent of Arg-gingipain protease activities.
Aduse-Opoku J; Davies NN; Gallagher A; Hashim A; Evans HEA; Rangarajan M; Slaney JM; Curtis MA
Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1933-1940. PubMed ID: 10931897
[TBL] [Abstract][Full Text] [Related]
7. Genetic analyses of proteolysis, hemoglobin binding, and hemagglutination of Porphyromonas gingivalis. Construction of mutants with a combination of rgpA, rgpB, kgp, and hagA.
Shi Y; Ratnayake DB; Okamoto K; Abe N; Yamamoto K; Nakayama K
J Biol Chem; 1999 Jun; 274(25):17955-60. PubMed ID: 10364243
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic Characteristics and Activities of Gingipains from Porphyromonas gingivalis.
Kadowaki T
Methods Mol Biol; 2021; 2210():97-112. PubMed ID: 32815131
[TBL] [Abstract][Full Text] [Related]
9. Porphyromonas gingivalis proteinases as virulence determinants in progression of periodontal diseases.
Kadowaki T; Nakayama K; Okamoto K; Abe N; Baba A; Shi Y; Ratnayake DB; Yamamoto K
J Biochem; 2000 Aug; 128(2):153-9. PubMed ID: 10920248
[TBL] [Abstract][Full Text] [Related]
10. Coordinate expression of the Porphyromonas gingivalis lysine-specific gingipain proteinase, Kgp, arginine-specific gingipain proteinase, RgpA, and the heme/hemoglobin receptor, HmuR.
Liu X; Sroka A; Potempa J; Genco CA
Biol Chem; 2004 Nov; 385(11):1049-57. PubMed ID: 15576325
[TBL] [Abstract][Full Text] [Related]
11. A novel, potent dual inhibitor of Arg-gingipains and Lys-gingipain as a promising agent for periodontal disease therapy.
Kataoka S; Baba A; Suda Y; Takii R; Hashimoto M; Kawakubo T; Asao T; Kadowaki T; Yamamoto K
FASEB J; 2014 Aug; 28(8):3564-78. PubMed ID: 24776743
[TBL] [Abstract][Full Text] [Related]
12. Cloning and sequencing of the gene encoding a novel lysine-specific cysteine proteinase (Lys-gingipain) in Porphyromonas gingivalis: structural relationship with the arginine-specific cysteine proteinase (Arg-gingipain).
Okamoto K; Kadowaki T; Nakayama K; Yamamoto K
J Biochem; 1996 Aug; 120(2):398-406. PubMed ID: 8889827
[TBL] [Abstract][Full Text] [Related]
13. Antibody responses of periodontitis patients to gingipains of Porphyromonas gingivalis.
Inagaki S; Ishihara K; Yasaki Y; Yamada S; Okuda K
J Periodontol; 2003 Oct; 74(10):1432-9. PubMed ID: 14653388
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a novel and potent inhibitor of Arg-gingipain from Streptomyces sp. strain FA-70.
Kadowaki T; Kitano S; Baba A; Takii R; Hashimoto M; Katunuma N; Yamamoto K
Biol Chem; 2003 Jun; 384(6):911-20. PubMed ID: 12887058
[TBL] [Abstract][Full Text] [Related]
15. Roles of Arg- and Lys-gingipains in coaggregation of Porphyromonas gingivalis: identification of its responsible molecules in translation products of rgpA, kgp, and hagA genes.
Abe N; Baba A; Takii R; Nakayama K; Kamaguchi A; Shibata Y; Abiko Y; Okamoto K; Kadowaki T; Yamamoto K
Biol Chem; 2004 Nov; 385(11):1041-7. PubMed ID: 15576324
[TBL] [Abstract][Full Text] [Related]
16. Roles for Arg- and Lys-gingipains in the disruption of cytokine responses and loss of viability of human endothelial cells by Porphyromonas gingivalis infection.
Baba A; Kadowaki T; Asao T; Yamamoto K
Biol Chem; 2002; 383(7-8):1223-30. PubMed ID: 12437109
[TBL] [Abstract][Full Text] [Related]
17. Involvement of arginine-specific cysteine proteinase (Arg-gingipain) in fimbriation of Porphyromonas gingivalis.
Nakayama K; Yoshimura F; Kadowaki T; Yamamoto K
J Bacteriol; 1996 May; 178(10):2818-24. PubMed ID: 8631669
[TBL] [Abstract][Full Text] [Related]
18. Comparative properties of envelope-associated arginine-gingipains and lysine-gingipain of Porphyromonas gingivalis.
Fujimura S; Hirai K; Shibata Y; Nakayama K; Nakamura T
FEMS Microbiol Lett; 1998 Jun; 163(2):173-9. PubMed ID: 9673019
[TBL] [Abstract][Full Text] [Related]
19. The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain.
Potempa J; Pike R; Travis J
Infect Immun; 1995 Apr; 63(4):1176-82. PubMed ID: 7890369
[TBL] [Abstract][Full Text] [Related]
20. Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes.
Potempa J; Sroka A; Imamura T; Travis J
Curr Protein Pept Sci; 2003 Dec; 4(6):397-407. PubMed ID: 14683426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
